This cooking tutorial provides step-by-step instructions on how to elevate three traditional BBQ side dishes—green beans, ...

Once exclusively a treatment for diabetes, GLP-1 medications have gone mainstream — forcing restaurants to adjust to changing appetites and nutrition needs. As GLP-1 medications normalize smaller ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

The Xreal 1S serves as a refreshed model in the One Series lineup, replacing the original Xreal One glasses from 2024. It features a Full HD 1200p display with a 16:10 aspect ratio and delivers peak ...

Posts from this topic will be added to your daily email digest and your homepage feed. Despite the spec bump, the Xreal 1S are $50 cheaper than their predecessor. Despite the spec bump, the Xreal 1S ...

If you’re looking for a simple, sweet treat to gift friends or family this holiday season, homemade peanut brittle is an easy win. The recipe is so straightforward you may not even need a trip to the ...

Novo Nordisk is seeking FDA approval for an experimental obesity shot, CagriSema (cagrilintide and semaglutide), according to a Dec. 18 news release from the Denmark-based drugmaker. CagriSema is a ...

Share on Pinterest Research suggests that GLP-1 drugs likely have little to no effect on risk for obesity-related cancers. Image credit: James Manning – PA Images/Getty Images In 2022, about 2.5 ...

GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...

Now, GLP-1s are available for weight loss, but plenty of misconceptions exist about how best to use these drugs. It may sound nice to think about taking GLP-1s and watching the numbers on your scale ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...